300869SZSE

Contec Medical Systems Co., Ltd.

康泰医学

300869

Shenzhen Stock Exchange

BoardChiNext of Shenzhen Stock Exchange
IndustrySpecial Machinery Manufacturing
ISINCNE1000047F0
ListedAugust 24, 2020
Websitewww.contecmed.com.cn
IR Emailcontec_sec@hotmail.com
Phone0335-8015593
Sourcecninfo.com.cn
AddressNo. 112, Qinhuang West Avenue, Economic and Technological Development Zone, Qinhuangdao, Hebei

Company Overview

Contec Medical Systems Co., Ltd. (CONTEC) is a Chinese company listed on the ChiNext board of the Shenzhen Stock Exchange since 2020. The company specializes in the research, development, production, and sales of medical diagnosis and monitoring equipment. CONTEC has developed three major product systems: hospital-use products, home-use products, and other products, which include a wide range of medical devices such as pulse oximeters, electrocardiographs, ultrasounds, patient monitors, sphygmomanometers, and IVD testing equipment. The company aims to provide diverse healthcare solutions and professional technical support to customers worldwide. CONTEC operates a mixed production model that includes make-to-order production, assembly, and inventory production, allowing for efficient operations and rapid order response. The company has a complete industrial chain that encompasses mold injection, software programming, and product assembly, ensuring high-quality control and cost management. With a marketing network that spans over 140 countries and regions, CONTEC employs a combination of distribution and direct sales strategies in domestic and international markets. The company is committed to continuous innovation and aims to enhance its product offerings to meet the evolving needs of the healthcare industry.

AI-generated from company disclosures and CNInfo data.

Company Profile

As one of the outstanding domestic medical device companies, CONTEC always regards independent R&D and innovation as the key factor for the survival, development and improvement of the overall competitiveness of the company. At present, CONTEC has mastered the core technology of pulse oximeter, patient monitor, ECG, Ultrasound, sphygmomanometer, analyzer and other various products. We can not only meet the diversified needs of customers for products, but also can quickly combine a variety of product functions according to the development trend of advanced technology and market demand to meet the needs of customers for the integration of medical device functions. CONTEC also has an innovative R&D team with excellent R&D capabilities and rich industry experience. Based on the development trend of advanced technology and market demand, the company continuously breaks through technical barriers and develops innovative products with high technological content and excellent quality. CONTEC is a manufacturing enterprise with a complete industrial chain. The production process covers mold injection, patch welding, software programming, product assembly and other links, enabling the company to ensure the quality of key inputs. Because the entire production process is autonomous and controllable, the company has the ability to provide customized products according to customer requirements, and can achieve the goal of consolidating existing customers and continuously attracting new customers. As one of the first domestic medical device brands that entered the overseas market, after years of operation, CONTEC has established a marketing network covering more than 140 countries and regions. and has accumulated a large number of high-quality domestic and foreign customer connections. The cost-effective products with excellent quality are widely recognized and trusted by customers both at home and abroad. CONTEC has established a multi-level and comprehensive quality management system covering R&D, purchasing, management, production, sales and after-sales service. Through the standardized operation of each link, the company's product performance and quality have reached a relatively high level. In addition, CONTEC pays great attention to customers and market needs, and always aims to provide customers with high-quality and convenient services. It has established a complete after-sales service system .

88 announcements tracked· Last: August 20, 2026

Key Financials

Revenue¥100.3M
Net Profit-¥8.2M
ROE-0.48%
Debt Ratio38.30%
Monetary Funds¥1.04bn
Receivables¥36.5M
Total Shares401.8M

Announcements

88 totalCSV

Notes & Comments

Sign in to leave a comment or private note.

No notes or comments yet.